Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1990 | 12-1989 | |
| Cash Flows From Operating Activities | ||
| Net Income | -4,077 | 1,401 |
| Depreciation Amortization | 896 | 738 |
| Other Working Capital | 249 | -1,797 |
| Other Operating Activity | 2,828 | 0 |
| Operating Cash Flow | $-104 | $342 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -1,738 | -1,280 |
| Other Investing Activity | 4,329 | -4,515 |
| Investing Cash Flow | $2,592 | $-5,795 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | -123 | 7,201 |
| Financing Cash Flow | $-123 | $7,201 |
| Beginning Cash Position | 5,247 | 3,499 |
| End Cash Position | 7,612 | 5,247 |
| Net Cash Flow | $2,365 | $1,748 |
| Free Cash Flow | ||
| Operating Cash Flow | -104 | 342 |
| Free Cash Flow | -104 | 342 |